3634 results for «203»

Filter By

3634 results

Transcatheter mitral valve replacement - LIVE case

20 May 2026 – From EuroPCR 2026

A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).

A transcatheter mitral...

Transcatheter mitral valve replacement - LIVE case

TAVI and coronary artery disease - LIVE case

19 May 2026 – From EuroPCR 2026

An 88-year-old woman with hypertension, dyslipidemia, paroxysmal AF, and moderate renal impairment presented with symptomatic severe aortic stenosis, with a small (396 mm²), horizontal annulus and preserved LV function. She also had CAD with severe OM and diagonal stenoses. CT showed a risk of left main...

TAVI and coronary artery disease - LIVE case

PCI of calcified distal left main stenosis - LIVE case

19 May 2026 – From EuroPCR 2026

A 54 year-old male with hypertention, smoker, dyslipidemia and history of OM and Diagnal PCI (2004) presented a significant LM-LAD calcified stenosis.

They prepared the proximal LAD lesion by IVL before implanted a 3.5-28 mm stent. Then, they prepared the LM lesion with NC predilatation, a cutting...

PCI of calcified distal left main stenosis - LIVE case

FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case

19 May 2026 – From EuroPCR 2026

A 71‑year‑old man with hypertension and dyslipidemia presented with CCS class II angina and three‑vessel coronary artery disease. Functional assessment included CT‑derived micro‑FFR, angiography‑based FFR, and stress myocardial scintigraphy. The only hemodynamically significant lesion was a long, calcified lesion of the LAD.

Lesion preparation was performed with...

FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case

TAVI in aortic regurgitation with a dedicated valve - LIVE case

20 May 2026 – From EuroPCR 2026

An 80-year-old male with chronic kidney disease, a history of colon cancer (2013), paroxysmal AF, and LAD PCI 2 weeks earlier presented with symptomatic severe type III AR. He had normal LV function, but early LV dilation. The mechanism of AR was a combination of primary...

TAVI in aortic regurgitation with a dedicated valve - LIVE case

Combined mitral repair and LAA closure with two separate septal punctures - LIVE case

21 May 2026 – From EuroPCR 2026

A 79‑year‑old man with hypertension, a history of basal cell carcinoma and psoriasis, presented with symptomatic severe primary MR (flail P2 due to ruptured chordae) and bleeding complications (recurrent skin bleeding) while on DOAC therapy for permanent atrial fibrillation.

Two G5 MitraClip devices were implanted. Subsequently, through...

Combined mitral repair and LAA closure with two separate septal punctures - LIVE case

Calcified lesion of distal protected left main - LIVE case

22 May 2026 – From EuroPCR 2026

An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...

Calcified lesion of distal protected left main - LIVE case

TAV-in-SAV TAVI procedure - LIVE case

21 May 2026 – From EuroPCR 2026

A 70‑year‑old man with COPD and a history of severe aortic stenosis treated with SAVR (27 mm Perimount Magna) in 2012, followed by endocarditis in 2013, presented with symptomatic degeneration of the surgical valve, predominantly as severe aortic regurgitation. Left ventricular function was preserved (LVEF 50%)...

TAV-in-SAV TAVI procedure - LIVE case

TAVI in extensive valve calcifications - LIVE case

22 May 2026 – From EuroPCR 2026

An 88‑year‑old woman with a history of dual‑chamber PPM and prior radiotherapy for breast cancer presented with symptomatic aortic stenosis and preserved left ventricular function.

A 27 mm Navitor Vision valve was implanted under local anesthesia using dual arterial access (femoral and right radial arteries).

LIVE Educational Case...

TAVI in extensive valve calcifications - LIVE case

BIOMAG-I clinical trial reaches primary endpoint at six month for unique next generation resorbable magnesium scaffold

23 Sep 2022

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial

31 Aug 2021

Luigi Biasco reports the best of Dj Lakkireddy (Overland Park, USA)'s presentation of the AMULET IDE trial at the Monday, August 30 Hot Line session of the ESC Congress 2021.

Luigi Biasco

Author

Luigi Biasco
ESC Congress 2021 - Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART

COVID-19 vaccines: Burning questions from the community and real-world applicability

13 Jan 2021

View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.

COVID-19 vaccines: Burning questions from the community and real-world applicability
Didn’t find what you were looking for?